User profiles for Andrew D. Badley
 | andrew badleyprofessor of infectious diseases Verified email at mayo.edu Cited by 10821 |
Mechanisms of HIV-associated lymphocyte apoptosis
Infection with the human immunodeficiency virus (HIV) is associated with a progressive
decrease in CD4 T-cell number and a consequent impairment in host immune defenses. …
decrease in CD4 T-cell number and a consequent impairment in host immune defenses. …
[PDF][PDF] FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system
Background Two US Food and Drug Administration (FDA)-authorized coronavirus disease
2019 (COVID-19) mRNA vaccines, BNT162b2 (Pfizer/BioNTech) and mRNA-1273 (Moderna)…
2019 (COVID-19) mRNA vaccines, BNT162b2 (Pfizer/BioNTech) and mRNA-1273 (Moderna)…
Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function
Objective To characterize immune phenotype and thymic function in HIV-1-infected adults
with excellent virologic and poor immunologic responses to highly active antiretroviral therapy …
with excellent virologic and poor immunologic responses to highly active antiretroviral therapy …
[HTML][HTML] Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis
The absence of immune defects that occurs in the syndrome of long-term nonprogressive (LTNP)
HIV infection offers insights into the pathophysiology of HIV-induced immune disease. …
HIV infection offers insights into the pathophysiology of HIV-induced immune disease. …
Macrophage-dependent Apoptosis of CD4+ T Lymphocytes from HIV-infected Individuals Is Mediated by FasL and Tumor Necrosis Factor
AD Badley, D Dockrell, M Simpson, R Schut… - The Journal of …, 1997 - rupress.org
Apoptosis of bystander uninfected CD4 + T lymphocytes by neighboring HIV-infected cells
is observed in cell culture and in lymphoid tissue of HIV-infected individuals. This study …
is observed in cell culture and in lymphoid tissue of HIV-infected individuals. This study …
[HTML][HTML] Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence
Although clinical trials and real-world studies have affirmed the effectiveness and safety of
the FDA-authorized COVID-19 vaccines, reports of breakthrough infections and persistent …
the FDA-authorized COVID-19 vaccines, reports of breakthrough infections and persistent …
[HTML][HTML] Casirivimab–Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19
…, AJ Venkatakrishnan, CG Wilker, AD Badley… - …, 2021 - thelancet.com
Background Real-world clinical data to support the use of casirivimab–imdevimab for the
treatment of outpatients with mild to moderate coronavirus disease-19 (COVID-19) is needed. …
treatment of outpatients with mild to moderate coronavirus disease-19 (COVID-19) is needed. …
Multi-organ impairment in low-risk individuals with long COVID
Background Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection has
disproportionately affected older individuals and those with underlying medical conditions. …
disproportionately affected older individuals and those with underlying medical conditions. …
Blockade of HERG channels by HIV protease inhibitors
The HIV protease inhibitor class of antiretroviral drug causes unpredicted adverse effects by
changing elements of normal cellular metabolism. A case of QT prolongation in a patient …
changing elements of normal cellular metabolism. A case of QT prolongation in a patient …
Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes
AD Badley, JA McElhinny, PJ Leibson… - Journal of …, 1996 - Am Soc Microbiol
Apoptosis has been proposed to mediate CD4+ T-cell depletion in human immunodeficiency
virus (HIV)-infected individuals. Interaction of Fas ligand (FasL) with Fas (CD95) results in …
virus (HIV)-infected individuals. Interaction of Fas ligand (FasL) with Fas (CD95) results in …
